Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$73.1 - $97.93 $138,305 - $185,283
1,892 Added 3.23%
60,545 $5.88 Million
Q3 2023

Nov 14, 2023

BUY
$80.15 - $92.62 $37,269 - $43,068
465 Added 0.8%
58,653 $4.74 Million
Q2 2023

Aug 14, 2023

BUY
$91.49 - $104.64 $223,235 - $255,321
2,440 Added 4.38%
58,188 $5.37 Million
Q1 2023

May 15, 2023

SELL
$92.92 - $109.35 $102,212 - $120,285
-1,100 Reduced 1.93%
55,748 $5.39 Million
Q4 2022

Feb 14, 2023

SELL
$84.9 - $102.89 $12,480 - $15,124
-147 Reduced 0.26%
56,848 $5.54 Million
Q3 2022

Nov 14, 2022

SELL
$90.51 - $207.38 $239,398 - $548,520
-2,645 Reduced 4.43%
56,995 $5.22 Million
Q2 2022

Aug 15, 2022

SELL
$87.94 - $101.67 $125,314 - $144,879
-1,425 Reduced 2.33%
59,640 $5.52 Million
Q1 2022

May 16, 2022

SELL
$85.56 - $107.12 $187,376 - $234,592
-2,190 Reduced 3.46%
61,065 $6.15 Million
Q4 2021

Feb 14, 2022

BUY
$97.41 - $116.74 $80,168 - $96,077
823 Added 1.32%
63,255 $6.69 Million
Q3 2021

Nov 15, 2021

SELL
$101.72 - $114.56 $4,170 - $4,696
-41 Reduced 0.07%
62,432 $6.62 Million
Q2 2021

Aug 16, 2021

BUY
$100.62 - $116.66 $216,433 - $250,935
2,151 Added 3.57%
62,473 $6.69 Million
Q1 2021

May 17, 2021

SELL
$95.11 - $111.11 $36,427 - $42,555
-383 Reduced 0.63%
60,322 $6.08 Million
Q4 2020

Feb 16, 2021

BUY
$101.34 - $117.74 $64,756 - $75,235
639 Added 1.06%
60,705 $6.63 Million
Q3 2020

Nov 16, 2020

BUY
$95.79 - $111.95 $252,981 - $295,659
2,641 Added 4.6%
60,066 $6.18 Million
Q2 2020

Aug 14, 2020

BUY
$90.75 - $104.91 $83,580 - $96,622
921 Added 1.63%
57,425 $5.67 Million
Q1 2020

May 15, 2020

BUY
$79.09 - $114.05 $565,888 - $816,027
7,155 Added 14.5%
56,504 $5.13 Million
Q4 2019

Feb 14, 2020

SELL
$77.9 - $98.54 $52,972 - $67,007
-680 Reduced 1.36%
49,349 $4.78 Million
Q3 2019

Nov 14, 2019

BUY
$74.21 - $82.92 $128,012 - $143,037
1,725 Added 3.57%
50,029 $3.97 Million
Q2 2019

Aug 14, 2019

BUY
$68.24 - $75.87 $101,541 - $112,894
1,488 Added 3.18%
48,304 $3.66 Million
Q1 2019

May 15, 2019

BUY
$65.72 - $71.66 $1.6 Million - $1.75 Million
24,414 Added 108.98%
46,816 $3.25 Million
Q4 2018

Feb 14, 2019

BUY
$61.31 - $73.73 $1.37 Million - $1.65 Million
22,402 New
22,402 $1.45 Million

Others Institutions Holding CSLLY

About CSL LTD


  • Ticker CSLLY
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 964,432,000
  • Market Cap $91.6B
  • Description
  • CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...
More about CSLLY
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.